David Shaw’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

David Shaw’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	+175,000	New	+$176K	﹤0.01%	4520

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

David Shaw's TDACW Position: Q2 2026 in Review

David Shaw opened a new position in Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026: 175,000 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #4520 among its holdings.

28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

David Shaw held 175,000 shares of Translational Development Acquisition Corp Warrants worth $231K as of Q2 2026.
Translational Development Acquisition Corp Warrants was a new David Shaw position in Q2 2026.
Translational Development Acquisition Corp Warrants made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4520 holding.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.